{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:00:17Z","timestamp":1794358817629,"version":"4.9.0"},"reference-count":178,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cyto.2024.156584","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T04:39:28Z","timestamp":1710823168000},"page":"156584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Understanding long COVID myocarditis: A comprehensive review"],"prefix":"10.1016","volume":"178","author":[{"given":"Arti","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Nalroad Sundararaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagriti","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharamvir","family":"Singh Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156584_b0005","doi-asserted-by":"crossref","unstructured":"Mokhtari, Tahmineh et al. \u201cCOVID-19 and multiorgan failure: A narrative review on potential mechanisms\u2019\u2019. Journal of Molecular Histology. 51(6) (2020): 613-628. 10.1007\/s10735-020-09915-3.","DOI":"10.1007\/s10735-020-09915-3"},{"key":"10.1016\/j.cyto.2024.156584_b0010","unstructured":"COVID-19 Epidemiological Update \u2013 22 December 2023.\u201d World Health Organization, World Health Organization, www.who.int\/publications\/m\/item\/covid-19-epidemiological-update---22-december-2023. Accessed 28 Dec. 2023."},{"key":"10.1016\/j.cyto.2024.156584_b0015","doi-asserted-by":"crossref","unstructured":"Siripanthong, Bhurint et al. \u201cRecognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management.\u201dHeart Rhythm. 17(9) (2020): 1463-1471. 10.1016\/j.hrthm.2020.05.001.","DOI":"10.1016\/j.hrthm.2020.05.001"},{"key":"10.1016\/j.cyto.2024.156584_b0020","doi-asserted-by":"crossref","unstructured":"Xie, Yan et al. \u201cLong-term cardiovascular outcomes of COVID-19.\u201dNature Medicine. 28(3) (2022): 583-590. 10.1038\/s41591-022-01689-3.","DOI":"10.1038\/s41591-022-01689-3"},{"key":"10.1016\/j.cyto.2024.156584_b0025","unstructured":"Post Covid-19 Condition (Long Covid).\u201d World Health Organization, World Health Organization, www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition. Accessed 28 Dec. 2023."},{"key":"10.1016\/j.cyto.2024.156584_b0030","unstructured":"Centers for Disease Control and Prevention. \u201cLong Covid or Post-Covid Conditions.\u201dCenters for Disease Control and Prevention, 20 July 2023, www.cdc.gov\/coronavirus\/2019-ncov\/long-term-effects\/index.html."},{"key":"10.1016\/j.cyto.2024.156584_b0035","unstructured":"COVID-19 rapid guideline: managing the long-term effects of COVID-19. National Institute for Health and Care Excellence (NICE), 18 December 2020."},{"key":"10.1016\/j.cyto.2024.156584_b0040","article-title":"\u201cDeterminants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study\u201d. the lancet regional health","volume":"33","author":"Mateu","year":"2023","journal-title":"Europe"},{"issue":"2","key":"10.1016\/j.cyto.2024.156584_b0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0830","article-title":"Sequelae in adults at 6 months after COVID-19 infection","volume":"4","author":"Logue","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cyto.2024.156584_b0050","doi-asserted-by":"crossref","unstructured":"Kim, Yoonjung et al. \u201cOne Year Follow-Up of COVID-19 Related Symptoms and Patient Quality of Life: A Prospective Cohort Study.\u201dYonsei Medical Journal. 63(6) (2022): 499-510. 10.3349\/ymj.2022.63.6.499.","DOI":"10.3349\/ymj.2022.63.6.499"},{"key":"10.1016\/j.cyto.2024.156584_b0055","doi-asserted-by":"crossref","unstructured":"Davis, Hannah E et al. \u201cCharacterizing long COVID in an international cohort: 7 months of symptoms and their impact.\u201dE Clinical Medicine. 38 (2021): 101019. 10.1016\/j.eclinm.2021.101019.","DOI":"10.1016\/j.eclinm.2021.101019"},{"issue":"11","key":"10.1016\/j.cyto.2024.156584_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240784","article-title":"Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection","volume":"15","author":"Townsend","year":"2020","journal-title":"PLoS One"},{"key":"#cr-split#-10.1016\/j.cyto.2024.156584_b0065.1","doi-asserted-by":"crossref","unstructured":"Puntmann, Valentina O et al. \"Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19).\"JAMA Cardiology. 5","DOI":"10.1001\/jamacardio.2020.3557"},{"key":"#cr-split#-10.1016\/j.cyto.2024.156584_b0065.2","unstructured":"(11) (2020): 1265-1273. 10.1001\/jamacardio.2020.3557."},{"key":"10.1016\/j.cyto.2024.156584_b0070","doi-asserted-by":"crossref","unstructured":"Xiong, Qiutang et al. \u201cClinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study.\u201dClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 27(1) (2021): 89-95. 10.1016\/j.cmi.2020.09.023.","DOI":"10.1016\/j.cmi.2020.09.023"},{"key":"10.1016\/j.cyto.2024.156584_b0075","doi-asserted-by":"crossref","unstructured":"Terzic, Carmen M, and Betsy J Medina-Inojosa. \u201cCardiovascular Complications of Coronavirus Disease-2019.\u201dPhysical Medicine and Rehabilitation Clinics of North America. 34(3) (2023): 551-561. 10.1016\/j.pmr.2023.03.003.","DOI":"10.1016\/j.pmr.2023.03.003"},{"key":"10.1016\/j.cyto.2024.156584_b0080","doi-asserted-by":"crossref","unstructured":"Paruchuri, Sai Sri Hari et al. \u201cMyocarditis and Myocardial Injury in Long COVID Syndrome: A Comprehensive Review of the Literature.\u201dCureus. 15 (7) e42444. (2023) 10.7759\/cureus.42444.","DOI":"10.7759\/cureus.42444"},{"key":"10.1016\/j.cyto.2024.156584_b0085","doi-asserted-by":"crossref","unstructured":"Giustino, Gennaro et al. \u201cCoronavirus and Cardiovascular Disease, Myocardial Injury, and rhythmia: JACCFocusSeminar.\u201dJournal of the American College of Cardiology. 76(17) (2020): 2011-2023. 10.1016\/j.jacc.2020.08.059.","DOI":"10.1016\/j.jacc.2020.08.059"},{"issue":"107263","key":"10.1016\/j.cyto.2024.156584_b0090","article-title":"Analysis of cardiopulmonary findings in COVID-19 fatalities: high incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Cardiovasc","volume":"49","author":"Grosse","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.cyto.2024.156584_b0095","doi-asserted-by":"crossref","unstructured":"Huseynov, Aydin et al. \u201cCardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment.\u201dViruses. 1592) 389. (2023), 10.3390\/v15020389.","DOI":"10.3390\/v15020389"},{"key":"10.1016\/j.cyto.2024.156584_b0100","unstructured":"Huang, Chaolin et al. \u201c6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.\u201dLancet (London, England). 397 (10270) (2021): 220-232. 10.1016\/S0140-6736(20)32656-8."},{"issue":"3","key":"10.1016\/j.cyto.2024.156584_b0105","doi-asserted-by":"crossref","first-page":"e023473","DOI":"10.1161\/JAHA.121.023473","article-title":"Cardiac dysfunction and arrhythmias 3 months after hospitalization for COVID-19","volume":"11","author":"Ingul","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cyto.2024.156584_b0110","doi-asserted-by":"crossref","unstructured":"Apicella, Matteo et al. \u201cCOVID-19 in people with diabetes: understanding the reasons for worse outcomes.\u201dThe lancet Diabetes & endocrinology. 8(9) (2020): 782-792. 10.1016\/S2213-8587(20)30238-2.","DOI":"10.1016\/S2213-8587(20)30238-2"},{"issue":"9","key":"10.1016\/j.cyto.2024.156584_b0115","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab448","article-title":"Sex and gender differences in testing, hospital admission, clinical presentation, and drivers of severe outcomes from COVID-19","volume":"8","author":"Scully","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.cyto.2024.156584_b0120","doi-asserted-by":"crossref","unstructured":"Thurner, Lorenz et al. \u201cIL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.\u201dThe New England Journal of Medicine. 387(16) (2022): 1524-1527. doi; 10.1056\/NEJMc2205667.","DOI":"10.1056\/NEJMc2205667"},{"issue":"1","key":"10.1016\/j.cyto.2024.156584_b0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cardfail.2020.11.002","article-title":"Clinically suspected Myocarditis in the course of severe acute respiratory syndrome novel Coronavirus-2 infection: fact or fiction?","volume":"27","author":"Ozieranski","year":"2021","journal-title":"J. Card. Fail."},{"issue":"1129348","key":"10.1016\/j.cyto.2024.156584_b0130","article-title":"Sex and gender differences in myocarditis and dilated cardiomyopathy: an update","volume":"10","author":"Fairweather","year":"2023","journal-title":"Frontiers in Cardiovascular Medicine."},{"issue":"5","key":"10.1016\/j.cyto.2024.156584_b0135","article-title":"SARS-CoV-2 Myocarditis due to severe obesity","volume":"13","author":"Farooqi","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.cyto.2024.156584_b0140","doi-asserted-by":"crossref","unstructured":"Frustaci, Andrea et al. \u201cHigh prevalence of myocarditis in patients with hypertensive heart disease and cardiac deterioration.\u201dEuropean journal of heart failure.15(3) (2013): 284-91. 10.1093\/eurjhf\/hfs169.","DOI":"10.1093\/eurjhf\/hfs169"},{"key":"10.1016\/j.cyto.2024.156584_b0145","doi-asserted-by":"crossref","unstructured":"Alvarez-Garcia, Jesus et al. \u201cPrognostic Impact of Prior HeartFailure in Patients Hospitalized With COVID-19.\u201dJournal of the American College of Cardiology. 76 (20) (2020): 2334-2348. 10.1016\/j.jacc.2020.09.549.","DOI":"10.1016\/j.jacc.2020.09.549"},{"key":"10.1016\/j.cyto.2024.156584_b0150","doi-asserted-by":"crossref","unstructured":"Sen, Saikat et al. \u201cDiabetes mellitus and COVID-19: Understanding the association in light of current evidence.\u201dWorld Journal of Clinical Cases. 9(28 (2021): 8327-8339.10.12998\/wjcc.v9.i28.8327.","DOI":"10.12998\/wjcc.v9.i28.8327"},{"issue":"11","key":"10.1016\/j.cyto.2024.156584_b0155","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.3390\/ijerph19116555","article-title":"Increased risk of COVID-19 in patients with diabetes mellitus-current challenges in pathophysiology, treatment and prevention","volume":"19","author":"G\u0119ca","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.cyto.2024.156584_b0160","doi-asserted-by":"crossref","unstructured":"Walls, Alexandra C et al. \u201cStructure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.\u201dCell. 181(2) (2020): 281-292.e6. 10.1016\/j.cell.2020.02.058.","DOI":"10.1016\/j.cell.2020.02.058"},{"key":"10.1016\/j.cyto.2024.156584_b0165","doi-asserted-by":"crossref","unstructured":"Santos, Robson Augusto Souza et al. \u201cThe ACE2\/Angiotensin-(1-7)\/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).\u201dPhysiological Reviews. 98(1) (2018): 505-553. 10.1152\/physrev.00023.2016.","DOI":"10.1152\/physrev.00023.2016"},{"issue":"2","key":"10.1016\/j.cyto.2024.156584_b0170","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. a first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.cyto.2024.156584_b0175","doi-asserted-by":"crossref","unstructured":"Hoffmann, Markus et al. \u201cSARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.\u201dCell. 181(2) (2020): 271-280.e8. 10.1016\/j.cell.2020.02.052.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"10.1016\/j.cyto.2024.156584_b0180","doi-asserted-by":"crossref","unstructured":"Kielian, Margaret. \u201cEnhancing host cell infection by SARS-CoV-2.\u201dScience (New York, N.Y.). 370(6518) (2020): 765-766. 10.1126\/science.abf0732.","DOI":"10.1126\/science.abf0732"},{"key":"10.1016\/j.cyto.2024.156584_b0185","doi-asserted-by":"crossref","unstructured":"Jaiswal, Vikash et al. \u201cCOVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review.\u201dJournal of Primary Care & Community Health. 12 (2021): 21501327211056800. 10.1177\/21501327211056800.","DOI":"10.1177\/21501327211056800"},{"key":"10.1016\/j.cyto.2024.156584_b0190","doi-asserted-by":"crossref","unstructured":"Gy\u00f6ngy\u00f6si, Mariann et al. \u201cLong COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases.\u201dCardiovascular Research. 119(2) (2023): 336-356. 10.1093\/cvr\/cvac115.","DOI":"10.1093\/cvr\/cvac115"},{"key":"10.1016\/j.cyto.2024.156584_b0195","doi-asserted-by":"crossref","unstructured":"Park, Kyung Chan et al. \u201cCardiac troponins: from myocardial infarction to chronic disease.\u201dCardiovascular Research. 113(14) (2017): 1708-1718. 10.1093\/cvr\/cvx183.","DOI":"10.1093\/cvr\/cvx183"},{"key":"10.1016\/j.cyto.2024.156584_b0200","doi-asserted-by":"crossref","unstructured":"Huang, Chaolin et al. \u201cClinical features of patients infected with 2019 novel coronavirus in Wuhan, China.\u201dLancet (London, England). 395(10223) (2020): 497-506. 10.1016\/S0140-6736(20)30183-5.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"issue":"1202332","key":"10.1016\/j.cyto.2024.156584_b0205","article-title":"Prevalence and impact of myocardial injury among patients hospitalized with COVID-19","volume":"10","author":"Hoang","year":"2023","journal-title":"Frontiers in Cardiovascular Medicine."},{"key":"10.1016\/j.cyto.2024.156584_b0210","doi-asserted-by":"crossref","unstructured":"Sandoval, Yader et al. \u201cCardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week.\u201dJournal of the American College of Cardiology. 76(10) (2020): 1244-1258. 10.1016\/j.jacc.2020.06.068.","DOI":"10.1016\/j.jacc.2020.06.068"},{"key":"10.1016\/j.cyto.2024.156584_b0215","doi-asserted-by":"crossref","unstructured":"Bouchaala, Abderrahmane et al. \u201cAcute symptomatic COVID-19 myocarditis: Case series.\u201dIHJ Cardiovascular Case Reports (CVCR)vol. 7,2 (2023): 53\u201357. 10.1016\/j.ihjccr.2023.05.004.","DOI":"10.1016\/j.ihjccr.2023.05.004"},{"key":"10.1016\/j.cyto.2024.156584_b0220","doi-asserted-by":"crossref","unstructured":"Dalen, Havard et al. \u201cAcute perimyocarditis with cardiac tamponade in COVID-19 infection without respiratory disease.\u201dBMJ case reportsvol. 13,8 e236218. 19 Aug. 2020, 10.1136\/bcr-2020-236218.","DOI":"10.1136\/bcr-2020-236218"},{"issue":"520","key":"10.1016\/j.cyto.2024.156584_b0225","article-title":"COVID-19-associated Myocarditis: an evolving concern in Cardiology and beyond","volume":"11","author":"Fraser","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.cyto.2024.156584_b0230","doi-asserted-by":"crossref","unstructured":"Artico, Jessica et al. \u201cMyocardial Involvement After Hospitalization for COVID-19 Complicated by Troponin Elevation: A Prospective, Multicenter, Observational Study.\u201dCirculation. 147(5) (2023): 364-374. 10.1161\/CIRCULATIONAHA.122.060632.","DOI":"10.1161\/CIRCULATIONAHA.122.060632"},{"key":"10.1016\/j.cyto.2024.156584_b0235","doi-asserted-by":"crossref","unstructured":"Tobler, Diana L et al. \u201cLong-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician.\u201dCurrent Atherosclerosis Reports. 24(7) (2022): 563-570. 10.1007\/s11883-022-01032-8.","DOI":"10.1007\/s11883-022-01032-8"},{"key":"#cr-split#-10.1016\/j.cyto.2024.156584_b0240.1","doi-asserted-by":"crossref","unstructured":"Guo, Tao et al. \"Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).\"JAMA Cardiology. 5","DOI":"10.1001\/jamacardio.2020.1017"},{"key":"#cr-split#-10.1016\/j.cyto.2024.156584_b0240.2","unstructured":"(7) (2020): 811-818. 10.1001\/jamacardio.2020.1017."},{"key":"10.1016\/j.cyto.2024.156584_b0245","doi-asserted-by":"crossref","unstructured":"Giacomet, Vania et al. \u201cAcute Inflammation and Elevated Cardiac Markers in a Two-Month-Old Infant with Severe Acute Respiratory Syndrome Coronavirus 2 Infection Presenting with Cardiac Symptoms.\u201dThe Pediatric Infectious Disease Journal. 39(7) (2020): e149-e151. 10.1097\/INF.0000000000002750.","DOI":"10.1097\/INF.0000000000002750"},{"key":"10.1016\/j.cyto.2024.156584_b0250","doi-asserted-by":"crossref","unstructured":"Nicol, Martin et al. \u201cDelayed acute myocarditis and COVID-19-related multisystem inflammatory syndrome.\u201dESC Heart Failure. 7(6) (2020): 4371-4376. 10.1002\/ehf2.13047.","DOI":"10.1002\/ehf2.13047"},{"key":"10.1016\/j.cyto.2024.156584_b0255","doi-asserted-by":"crossref","unstructured":"Pranata, Raymond et al. \u201cElevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis.\u201dPostgraduate Medical Journal. 96(1137) (2020): 387-391. 10.1136\/postgradmedj-2020-137884.","DOI":"10.1136\/postgradmedj-2020-137884"},{"key":"10.1016\/j.cyto.2024.156584_b0260","doi-asserted-by":"crossref","unstructured":"Shafi, Ahmed M A et al. \u201cCardiac manifestations in COVID-19 patients-A systematic review.\u201dJournal of Cardiac Surgery. 35(8) (2020): 1988-2008. 10.1111\/jocs.14808.","DOI":"10.1111\/jocs.14808"},{"issue":"6","key":"10.1016\/j.cyto.2024.156584_b0265","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s10753-022-01680-7","article-title":"The lactate and the lactate dehydrogenase in inflammatory diseases and major risk factors in COVID-19 patients","volume":"45","author":"Gupta","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.cyto.2024.156584_b0270","doi-asserted-by":"crossref","unstructured":"Chen, Jianjun et al. \u201cResearch advances in myocardial injury caused by COVID-19.\u201dCardiovascular diagnosis and therapyvol. 10,4 (2020): 881-887. 10.21037\/cdt-20-349.","DOI":"10.21037\/cdt-20-349"},{"key":"10.1016\/j.cyto.2024.156584_b0275","doi-asserted-by":"crossref","unstructured":"Li, Chang et al. \u201cElevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19.\u201dAging. 12(15) (2020): 15670-15681. 10.18632\/aging.103770.","DOI":"10.18632\/aging.103770"},{"issue":"11","key":"10.1016\/j.cyto.2024.156584_b0280","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/jmv.26097","article-title":"Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19","volume":"92","author":"Ali","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cyto.2024.156584_b0285","doi-asserted-by":"crossref","first-page":"P291","DOI":"10.1186\/1532-429X-17-S1-P291","article-title":"Role of C Reactive Protein in Evaluating the Extent of Myocardial Inflammation in Acute Myocarditis","volume":"17","author":"Goitein","year":"2015","journal-title":"J. Cardiovascular Magnetic Res."},{"issue":"3","key":"10.1016\/j.cyto.2024.156584_b0290","first-page":"384","article-title":"C-reactive protein, inflammation, and cardiovascular disease: clinical update","volume":"32","author":"Ridker","year":"2005","journal-title":"Tex. Heart Inst. J."},{"issue":"6","key":"10.1016\/j.cyto.2024.156584_b0295","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01740811","article-title":"Procalcitonin\u2013a new indicator of the systemic response to severe infections","volume":"25","author":"Karzai","year":"1997","journal-title":"Infection"},{"key":"10.1016\/j.cyto.2024.156584_b0300","doi-asserted-by":"crossref","unstructured":"Zhang, Yan et al. \u201cDiagnostic Value and Prognostic Significance of Procalcitonin Combined with C-Reactive Protein in Patients with Bacterial Bloodstream Infection.\u201dComputational and Mathematical Methods in Medicine. 6989229(2022), 10.1155\/2022\/6989229.","DOI":"10.1155\/2022\/6989229"},{"key":"10.1016\/j.cyto.2024.156584_b0305","doi-asserted-by":"crossref","unstructured":"Hu, Rui et al. \u201cProcalcitonin levels in COVID-19 patients.\u201dInternational Journal of antimicrobial agents. 56(2) (2020): 106051. 10.1016\/j.ijantimicag.2020.106051.","DOI":"10.1016\/j.ijantimicag.2020.106051"},{"key":"10.1016\/j.cyto.2024.156584_b0310","doi-asserted-by":"crossref","unstructured":"Chen, Ken et al. \u201cProcalcitonin for Antibiotic Prescription in Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective.\u201dPulmonary therapy. 6(2) (2020): 201-214. 10.1007\/s41030-020-00123-8.","DOI":"10.1007\/s41030-020-00123-8"},{"key":"#cr-split#-10.1016\/j.cyto.2024.156584_b0315.1","unstructured":"Lippi, Giuseppe, and Mario Plebani. \"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.\"Clinica chimica acta"},{"key":"#cr-split#-10.1016\/j.cyto.2024.156584_b0315.2","unstructured":"International Journal of clinical chemistry. 505 (2020): 190-191. 10.1016\/j.cca.2020.03.004."},{"issue":"19","key":"10.1016\/j.cyto.2024.156584_b0320","article-title":"\u201cCOVID-19 related Myocarditis in adults: a systematic review of case reports\u201d. journal of","volume":"11","author":"Urban","year":"2022","journal-title":"Clin. Med."},{"issue":"9","key":"10.1016\/j.cyto.2024.156584_b0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272840","article-title":"Procalcitonin as a predictive marker in COVID-19: a systematic review and meta-analysis","volume":"17","author":"Kumar","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cyto.2024.156584_b0330","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5005\/jp-journals-10071-23741","article-title":"Presepsin: a promising Biomarker for sepsis","volume":"25","author":"Azim","year":"2021","journal-title":"Indian J. Critical Care Med."},{"issue":"1","key":"10.1016\/j.cyto.2024.156584_b0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191486","article-title":"Prognostic value of presepsin in adult patients with sepsis: systematic review and meta-analysis","volume":"13","author":"Yang","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cyto.2024.156584_b0340","doi-asserted-by":"crossref","DOI":"10.1186\/cc13183","article-title":"Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the albumin italian outcome sepsis trial","volume":"18","author":"Masson","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.cyto.2024.156584_b0345","doi-asserted-by":"crossref","unstructured":"Toprak, Kenan et al. \u201cCould Zonulin and Presepsin Be Biomarkers and Therapeutic Targets for Acute Myocarditis?.\u201d \u201cZonulina e Presepsina Poderiam ser Biomarcadores e Alvos Terap\u00eauticos para Miocardite Aguda?.\u201dArquivos brasileiros de cardiologia. 120(8) (2023): e20230017. 10.36660\/abc.20230017.","DOI":"10.36660\/abc.20230017"},{"key":"10.1016\/j.cyto.2024.156584_b0350","doi-asserted-by":"crossref","unstructured":"Guarino, Matteo et al. \u201cPresepsin levels and COVID-19 severity: a systematic review and meta-analysis.\u201dClinical and Experimental Medicine. 23 (4) (2023): 993-1002. 10.1007\/s10238-022-00936-8.","DOI":"10.1007\/s10238-022-00936-8"},{"key":"10.1016\/j.cyto.2024.156584_b0355","article-title":"Presepsin value predicts the risk of developing severe\/critical COVID-19 illness: results of a pooled analysis","volume":"60","author":"Lippi","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cyto.2024.156584_b0360","doi-asserted-by":"crossref","unstructured":"Lippi, Giuseppe, Sanchis-Gomar, Fabian and Henry, Brandon M.. \u201cPresepsin value predicts the risk of developing severe\/critical COVID-19 illness: results of a pooled analysis\u201dClinical Chemistry and Laboratory Medicine (CCLM). 60 (1) (2022).https:\/\/doi.org\/10.1515\/cclm-2021-0848.","DOI":"10.1515\/cclm-2021-0848"},{"key":"10.1016\/j.cyto.2024.156584_b0365","doi-asserted-by":"crossref","unstructured":"Park, Mikyoung et al. \u201cPrognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients.\u201dAnnals of Laboratory Medicine. 424 (2022): 406-414. 10.3343\/alm.2022.42.4.406.","DOI":"10.3343\/alm.2022.42.4.406"},{"key":"10.1016\/j.cyto.2024.156584_b0370","doi-asserted-by":"crossref","unstructured":"Homsak, Evgenija, and Damien Gruson. \u201cSoluble ST2: A complex and diverse role in several diseases.\u201dClinica chimica acta; International Journal of Clinical Chemistry. 507 (2020): 75-87. 10.1016\/j.cca.2020.04.011.","DOI":"10.1016\/j.cca.2020.04.011"},{"key":"10.1016\/j.cyto.2024.156584_b0375","doi-asserted-by":"crossref","unstructured":"Bajwa, Ednan K et al. \u201cPrognostic and diagnostic value of plasma soluble suppression of tumorigenicity-2 concentrations in acute respiratory distress syndrome.\u201dCritical Care Medicine. 41(11) (2013): 2521-31. 10.1097\/CCM.0b013e3182978f91.","DOI":"10.1097\/CCM.0b013e3182978f91"},{"key":"10.1016\/j.cyto.2024.156584_b0380","doi-asserted-by":"crossref","unstructured":"Bajwa, Ednan K et al. \u201cST2 in Pulmonary Disease.\u201dThe American Journal of Cardiology. 115(7) Suppl (2015): 44B-7B. 10.1016\/j.amjcard.2015.01.040.","DOI":"10.1016\/j.amjcard.2015.01.040"},{"issue":"7","key":"10.1016\/j.cyto.2024.156584_b0385","doi-asserted-by":"crossref","first-page":"e024417","DOI":"10.1161\/JAHA.121.024417","article-title":"Soluble ST2 is a sensitive and specific Biomarker for fulminant Myocarditis","volume":"11","author":"Wang","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cyto.2024.156584_b0390","doi-asserted-by":"crossref","unstructured":"Kirk, Jonathan A, and Nikolaos G Frangogiannis. \u201cGalectin-3 in the pathogenesis of heart failure: a causative mediator or simply a biomarker?.\u201dAmerican Journal of Physiology. Heart and Circulatory Physiology. 314(6) (2018): H1256-H1258. 10.1152\/ajpheart.00150.2018.","DOI":"10.1152\/ajpheart.00150.2018"},{"key":"10.1016\/j.cyto.2024.156584_b0395","doi-asserted-by":"crossref","unstructured":"Zhang, Chi et al. \u201cCytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.\u201dInternational journal of antimicrobial agents. 55(5) (2020): 105954. 10.1016\/j.ijantimicag.2020.105954.","DOI":"10.1016\/j.ijantimicag.2020.105954"},{"key":"10.1016\/j.cyto.2024.156584_b0400","doi-asserted-by":"crossref","unstructured":"Chen, Swey-Shen et al. \u201cDownregulating galectin-3 inhibits proinflammatory cytokine production by human monocyte-derived dendritic cells via RNA interference.\u201dCellular Immunology. 294(1) (2015): 44-53. 10.1016\/j.cellimm.2015.01.017.","DOI":"10.1016\/j.cellimm.2015.01.017"},{"key":"10.1016\/j.cyto.2024.156584_b0405","doi-asserted-by":"crossref","unstructured":"Noguchi, Kei et al. \u201cTime-course analysis of cardiac and serum galectin-3 in viral myocarditis after an encephalomyocarditis virus inoculation.\u201dPloS onevol. 14,1 e0210971. 23 Jan. 2019, 10.1371\/journal.pone.0210971.","DOI":"10.1371\/journal.pone.0210971"},{"issue":"3","key":"10.1016\/j.cyto.2024.156584_b0410","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrendo.2015.224","article-title":"Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis","volume":"12","author":"Christ-Crain","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cyto.2024.156584_b0415","doi-asserted-by":"crossref","unstructured":"Maisel, Alan et al. \u201cIncreased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.\u201dCirculation. Heart Failure. 4(5) (2011): 613-20. 10.1161\/CIRCHEARTFAILURE.110.960096.","DOI":"10.1161\/CIRCHEARTFAILURE.110.960096"},{"key":"10.1016\/j.cyto.2024.156584_b0420","doi-asserted-by":"crossref","unstructured":"Muthyala, Anjani et al. \u201cUtility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.\u201dWorld Journal of Virology. 11(5) (2022): 375-390. 10.5501\/wjv.v11.i5.375.","DOI":"10.5501\/wjv.v11.i5.375"},{"key":"10.1016\/j.cyto.2024.156584_b0425","doi-asserted-by":"crossref","unstructured":"Gregoriano, Claudia et al. \u201cActivation of Vasopressin System During COVID-19 is Associated With Adverse Clinical Outcomes: An Observational Study.\u201dJournal of the Endocrine Society. 5(6)(2021). 10.1210\/jendso\/bvab045.","DOI":"10.1210\/jendso\/bvab045"},{"key":"10.1016\/j.cyto.2024.156584_b0430","doi-asserted-by":"crossref","unstructured":"Hammad, Reham et al. \u201cCopeptin: a neuroendocrine biomarker of COVID-19 severity.\u201dBiomarkers in Medicine. 16(8) (2022): 589-597. 10.2217\/bmm-2021-1100.","DOI":"10.2217\/bmm-2021-1100"},{"key":"10.1016\/j.cyto.2024.156584_b0435","doi-asserted-by":"crossref","unstructured":"Ukena, Christian et al. \u201cDiagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis.\u201dClinical research in cardiology : official journal of the German Cardiac Society. 103(9) (2014): 743-51. 10.1007\/s00392-014-0709-z.","DOI":"10.1007\/s00392-014-0709-z"},{"issue":"1","key":"10.1016\/j.cyto.2024.156584_b0440","article-title":"Emerging Biomarkers for predicting clinical outcomes in patients with Heart disease","volume":"13","author":"P\u00e1l","year":"2023","journal-title":"Life (basel, Switzerland)"},{"key":"10.1016\/j.cyto.2024.156584_b0445","doi-asserted-by":"crossref","unstructured":"May, Bruna Miers et al. \u201cGDF-15 as a Biomarker in Cardiovascular Disease.\u201d \u201cGDF-15 como Biomarcador em Doen\u00e7as Cardiovasculares.\u201dArquivos brasileiros de cardiologia. 116(3) (2021): 494-500. 10.36660\/abc.20200426.","DOI":"10.36660\/abc.20200426"},{"key":"10.1016\/j.cyto.2024.156584_b0450","doi-asserted-by":"crossref","unstructured":"Vardeny, Orly et al. \u201cEfficacy of sacubitril\/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.\u201dEuropean Journal of Heart Failure. 18(10) (2016): 1228-1234. 10.1002\/ejhf.580.","DOI":"10.1002\/ejhf.580"},{"key":"10.1016\/j.cyto.2024.156584_b0455","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156584_b0460","doi-asserted-by":"crossref","unstructured":"Sivakorn, Chaisith et al. \u201cHigh Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients.\u201dThe American Journal of Tropical Medicine and Hygiene. 105(1) (2021):73-80. 10.4269\/ajtmh.21-0165.","DOI":"10.4269\/ajtmh.21-0165"},{"key":"10.1016\/j.cyto.2024.156584_b0465","doi-asserted-by":"crossref","unstructured":"McGonagle, Dennis et al. \u201cThe Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.\u201dAutoimmunity Reviews. 19(6) (2020): 102537. 10.1016\/j.autrev.2020.102537.","DOI":"10.1016\/j.autrev.2020.102537"},{"issue":"6","key":"10.1016\/j.cyto.2024.156584_b0470","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1097\/MS9.0000000000000679","article-title":"IL1\u03b2, IL-6, and TNF-\u03b1 cytokines cooperate to modulate a complicated medical condition among COVID-19 patients: case-control study","volume":"85","author":"Faraj","year":"2012","journal-title":"Ann. Med. Surgery"},{"key":"10.1016\/j.cyto.2024.156584_b0475","doi-asserted-by":"crossref","unstructured":"Han, Huan et al. \u201cProfiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.\u201dEmerging Microbes & Infections. 9(1) (2020): 1123-1130. 10.1080\/22221751.2020.1770129.","DOI":"10.1080\/22221751.2020.1770129"},{"key":"10.1016\/j.cyto.2024.156584_b0480","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.667721","article-title":"Myocardial work efficiency, a novel measure of Myocardial dysfunction, is reduced in COVID-19 patients and associated with in-hospital mortality","volume":"8","author":"Minhas","year":"2021","journal-title":"Front. Cardiovascular Medicine."},{"key":"10.1016\/j.cyto.2024.156584_b0485","doi-asserted-by":"crossref","unstructured":"Pathan, Nazima et al. \u201cRole of interleukin 6 in myocardial dysfunction of meningococcal septic shock.\u201dLancet (London, England). 363(9404) (2004): 203-9. 10.1016\/S0140-6736(03)15326-3.","DOI":"10.1016\/S0140-6736(03)15326-3"},{"key":"10.1016\/j.cyto.2024.156584_b0490","doi-asserted-by":"crossref","unstructured":"Kociol, Robb D et al. \u201cRecognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association.\u201dCirculation. 141(6) (2020): e69-e92. 10.1161\/CIR.0000000000000745.","DOI":"10.1161\/CIR.0000000000000745"},{"key":"10.1016\/j.cyto.2024.156584_b0495","doi-asserted-by":"crossref","unstructured":"Skouri, Hadi N et al. \u201cNoninvasive imaging in myocarditis.\u201dJournal of the American College of Cardiology. 48(10) (2006): 2085-93. 10.1016\/j.jacc.2006.08.017.","DOI":"10.1016\/j.jacc.2006.08.017"},{"issue":"8","key":"10.1016\/j.cyto.2024.156584_b0500","doi-asserted-by":"crossref","first-page":"e19223","DOI":"10.1097\/MD.0000000000019223","article-title":"A case report on transient global ventricular wall thickening secondary to acute myocarditis: focus on the unique role of cardiac MRI","volume":"99","author":"Xu","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.cyto.2024.156584_b0505","doi-asserted-by":"crossref","unstructured":"Shillcutt, Sasha K et al. \u201cFulminant myocarditis: the role of perioperative echocardiography.\u201dAnesthesia and analgesia. 120(2) (2015): 296-9. 10.1213\/ANE.0000000000000508.","DOI":"10.1213\/ANE.0000000000000508"},{"key":"10.1016\/j.cyto.2024.156584_b0510","doi-asserted-by":"crossref","unstructured":"Ammirati, Enrico et al. \u201cSurvival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis.\u201dCirculation. 136(6) (2017): 529-545. 10.1161\/CIRCULATIONAHA.117.026386.","DOI":"10.1161\/CIRCULATIONAHA.117.026386"},{"issue":"9","key":"10.1016\/j.cyto.2024.156584_b0515","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/ehjci\/jev302","article-title":"Myocardial oedema in acute myocarditis detected by echocardiographic 2D myocardial deformation analysis","volume":"17","author":"L\u00f8gstrup","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"10235","key":"10.1016\/j.cyto.2024.156584_b0520","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/S0140-6736(20)30912-0","article-title":"Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes","volume":"395","author":"Doyen","year":"2020","journal-title":"Lancet (london, England)"},{"key":"10.1016\/j.cyto.2024.156584_b0525","doi-asserted-by":"crossref","unstructured":"Motwani, Manish et al. \u201cAdvances in cardiovascular magnetic resonance in ischaemic heart disease and non-ischaemic cardiomyopathies.\u201dHeart (British Cardiac Society). 100(21) (2014): 1722-33. 10.1136\/heartjnl-2013-304680.","DOI":"10.1136\/heartjnl-2013-304680"},{"key":"10.1016\/j.cyto.2024.156584_b0530","doi-asserted-by":"crossref","unstructured":"Ferreira, Vanessa M et al. \u201cCardiovascular Magnetic Resonance in NonischemicMyocardial Inflammation: Expert Recommendations.\u201dJournal of the American College of Cardiology. 72(24) (2018): 3158-3176. 10.1016\/j.jacc.2018.09.072.","DOI":"10.1016\/j.jacc.2018.09.072"},{"key":"10.1016\/j.cyto.2024.156584_b0535","doi-asserted-by":"crossref","unstructured":"Luetkens, Julian A et al. \u201cComparison of Original and 2018 Lake Louise Criteria for Diagnosis of Acute Myocarditis: Results of a Validation Cohort.\u201dRadiology. Cardiothoracic imaging. 1(3)(2019). 10.1148\/ryct.2019190010.","DOI":"10.1148\/ryct.2019190010"},{"issue":"737257","key":"10.1016\/j.cyto.2024.156584_b0540","article-title":"COVID-19 vs. classical Myocarditis associated Myocardial injury evaluated by Cardiac magnetic resonance and Endomyocardial biopsy","volume":"8","author":"Tanacli","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine."},{"issue":"12","key":"10.1016\/j.cyto.2024.156584_b0545","doi-asserted-by":"crossref","first-page":"e05236","DOI":"10.1002\/ccr3.5236","article-title":"Clinically suspected myocarditis in COVID-19 patients: case series and review of the literature","volume":"9","author":"Amin","year":"2021","journal-title":"Clinical Case Reports."},{"key":"10.1016\/j.cyto.2024.156584_b0550","doi-asserted-by":"crossref","unstructured":"Garau, Giovanni et al. \u201cSudden cardiogenic shock mimicking fulminant myocarditis in a surviving teenager affected by severe acute respiratory syndrome coronavirus 2 infection.\u201dESC Heart Failure. 8(1) (2021): 766-773. 10.1002\/ehf2.13049.","DOI":"10.1002\/ehf2.13049"},{"key":"10.1016\/j.cyto.2024.156584_b0555","article-title":"COVID-19 cardiac injury and the use of colchicine","volume":"14(2) e241047","author":"Anton-Vazquez","year":"2021","journal-title":"BMJ Case Reports."},{"key":"10.1016\/j.cyto.2024.156584_b0560","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/heartjnl-2013-304680","article-title":"Advances in cardiovascular magnetic resonance in ischaemic heart disease and non-ischaemic cardiomyopathies","volume":"100","author":"Motwani","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.cyto.2024.156584_b0565","doi-asserted-by":"crossref","unstructured":"Clemente, Alberto et al. \u201cCardiac CT angiography: normal and pathological anatomical features-a narrative review.\u201dCardiovascular diagnosis and therapyvol. 10,6 (2020): 1918-1945. 10.21037\/cdt-20-530.","DOI":"10.21037\/cdt-20-530"},{"issue":"1","key":"10.1016\/j.cyto.2024.156584_b0570","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2007.10.053","article-title":"Myopericarditis: etiology, management, and prognosis","volume":"127","author":"Imazio","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cyto.2024.156584_b0575","doi-asserted-by":"crossref","unstructured":"Mele, Donato et al. \u201cMyocarditis in COVID-19 patients: current problems.\u201dInternal and Emergency Medicine. 16(5) (2021): 1123-1129. 10.1007\/s11739-021-02635-w.","DOI":"10.1007\/s11739-021-02635-w"},{"key":"10.1016\/j.cyto.2024.156584_b0580","doi-asserted-by":"crossref","unstructured":"Ammirati, Enrico et al. \u201cState-of-the-Art of Endomyocardial Biopsy on Acute Myocarditis and Chronic Inflammatory Cardiomyopathy.\u201dCurrent Cardiology Reports. 24(5) (2022): 597-609. 10.1007\/s11886-022-01680-x.","DOI":"10.1007\/s11886-022-01680-x"},{"key":"10.1016\/j.cyto.2024.156584_b0585","doi-asserted-by":"crossref","unstructured":"Heymans, Stephane et al. \u201cThe Quest for New Approaches inMyocarditis and InflammatoryCardiomyopathy.\u201dJournal of the American College of Cardiology. 68(21) (2016): 2348-2364. 10.1016\/j.jacc.2016.09.937.","DOI":"10.1016\/j.jacc.2016.09.937"},{"key":"10.1016\/j.cyto.2024.156584_b0590","doi-asserted-by":"crossref","unstructured":"Kandolin, Riina et al. \u201cDiagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression.\u201dCirculation. Heart failure. 6(1) (2013): 15-22. 10.1161\/CIRCHEARTFAILURE.112.969261.","DOI":"10.1161\/CIRCHEARTFAILURE.112.969261"},{"key":"10.1016\/j.cyto.2024.156584_b0595","doi-asserted-by":"crossref","unstructured":"Shields, Raymond C et al. \u201cThe role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis.\u201dJournal of Cardiac Failure. 8(2) (2002): 74-8. 10.1054\/jcaf.2002.32196.","DOI":"10.1054\/jcaf.2002.32196"},{"key":"10.1016\/j.cyto.2024.156584_b0600","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9943937","article-title":"COVID-19 induced Cardiomyopathy successfully treated with tocilizumab","author":"Schreiber","year":"2022","journal-title":"Case Reports Cardiology"},{"issue":"4","key":"10.1016\/j.cyto.2024.156584_b0605","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcr\/ytac142","article-title":"Fulminant Delta COVID-19 myocarditis: a case report of fatal primary cardiac dysfunction","volume":"6","author":"Thomson","year":"2022","journal-title":"Eur. Heart J. Case Reports."},{"key":"10.1016\/j.cyto.2024.156584_b0610","doi-asserted-by":"crossref","unstructured":"Shahrami, Bita et al. \u201cManagement of a critically ill patient with COVID-19-related fulminant myocarditis: A case report.\u201dRespiratory Medicine Case Reports. 36 (2022): 101611. 10.1016\/j.rmcr.2022.101611.","DOI":"10.1016\/j.rmcr.2022.101611"},{"issue":"12","key":"10.1016\/j.cyto.2024.156584_b0615","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jiac.2021.08.007","article-title":"Coronavirus disease (COVID-19) associated delayed-onset fulminant myocarditis in patient with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"27","author":"Ishikura","year":"2021","journal-title":"J. Infection Chemotherapy"},{"key":"10.1016\/j.cyto.2024.156584_b0620","doi-asserted-by":"crossref","unstructured":"Bulbul, Rajai F et al. \u201cCOVID -19 Complicated By Acute Respiratory Distress Syndrome, Myocarditis, and Pulmonary Embolism. A Case Report.\u201dJournal of Critical Care Medicine (Universitatea de Medicina si Farmacie din Targu-Mures). 7(2) (2021);123-129. 10.2478\/jccm-2020-0041.","DOI":"10.2478\/jccm-2020-0041"},{"key":"10.1016\/j.cyto.2024.156584_b0625","doi-asserted-by":"crossref","unstructured":"Meel, Ruchika, and Sarah A Van Blydenstein. \u201cDemographic, clinical, electrocardiographic and echocardiographic characteristics of patients hospitalized with COVID-19 and cardiac disease at a tertiary hospital, South Africa.\u201dCardiovascular diagnosis and therapy. 11(6) (2021): 1228-1240. 10.21037\/cdt-21-459.","DOI":"10.21037\/cdt-21-459"},{"key":"10.1016\/j.cyto.2024.156584_b0630","doi-asserted-by":"crossref","unstructured":"Meyer, Maxence et al. \u201cPresence of active myocarditis at the 6month follow-up appointment for a severe form of COVID-19: a case report.\u201dESC Heart Failure. 8(5) (2021): 4307-4312. 10.1002\/ehf2.13461.","DOI":"10.1002\/ehf2.13461"},{"issue":"7","key":"10.1016\/j.cyto.2024.156584_b0635","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-244027","article-title":"COVID-19-associated myocarditis presenting as new-onset heart failure and atrial fibrillation","volume":"14","author":"Gaine","year":"2021","journal-title":"BMJ Case Reports."},{"key":"10.1016\/j.cyto.2024.156584_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2021.102313","article-title":"ST elevation revealing acute myocarditis with SARS Cov-2 infection: case report","volume":"65","author":"Taouihar","year":"2021","journal-title":"Ann. Med. Surgery."},{"key":"10.1016\/j.cyto.2024.156584_b0645","doi-asserted-by":"crossref","unstructured":"Coyle, Justin et al. \u201cA Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001.\u201dJACC. Case reports. 2(9) (2020): 1331-1336. 10.1016\/j.jaccas.2020.04.025.","DOI":"10.1016\/j.jaccas.2020.04.025"},{"key":"#cr-split#-10.1016\/j.cyto.2024.156584_b0650.1","doi-asserted-by":"crossref","unstructured":"Hudowenz, Ole et al. \"Case report of severe PCR-confirmed COVID-19 myocarditis in a European patient manifesting in mid-January 2020.\"European Heart Journal. Case reports. 4","DOI":"10.1093\/ehjcr\/ytaa286"},{"key":"#cr-split#-10.1016\/j.cyto.2024.156584_b0650.2","unstructured":"(6) (2020): 1-6. 10.1093\/ehjcr\/ytaa286."},{"key":"#cr-split#-10.1016\/j.cyto.2024.156584_b0655.1","doi-asserted-by":"crossref","unstructured":"Gay, Hawkins C et al. \"Fulminant myocarditis in a patient with coronavirus disease 2019 and rapid myocardial recovery following treatment.\"ESC Heart failure. 7","DOI":"10.1002\/ehf2.13041"},{"key":"#cr-split#-10.1016\/j.cyto.2024.156584_b0655.2","unstructured":"(6) (2020): 4367-4370. 10.1002\/ehf2.13041."},{"key":"10.1016\/j.cyto.2024.156584_b0660","first-page":"e9179","article-title":"An typical presentation of fulminant Myocarditis Secondary to COVID-19 infection","volume":"127","author":"Richard","year":"2020","journal-title":"Cureus."},{"key":"10.1016\/j.cyto.2024.156584_b0665","doi-asserted-by":"crossref","unstructured":"Tavazzi, Guido et al. \u201cMyocardial localization of coronavirus in COVID-19 cardiogenic shock.\u201dEuropean Journal of Heart Failure. 22(5) (2020): 911-915. 10.1002\/ejhf.1828.","DOI":"10.1002\/ejhf.1828"},{"key":"10.1016\/j.cyto.2024.156584_b0670","doi-asserted-by":"crossref","unstructured":"Paul, Jean-Fran\u00e7ois et al. \u201cMyocarditis revealing COVID-19 infection in a young patient.\u201dEuropean Heart Journal. Cardiovascular Imaging. 21(7) (2020): 776. 10.1093\/ehjci\/jeaa107.","DOI":"10.1093\/ehjci\/jeaa107"},{"issue":"6","key":"10.1016\/j.cyto.2024.156584_b0675","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.hrtlng.2020.06.003","article-title":"Coronavirus disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade: a case report and literature review","volume":"49","author":"Khatri","year":"2020","journal-title":"Heart & Lung: the Journal of Critical Care."},{"key":"10.1016\/j.cyto.2024.156584_b0680","doi-asserted-by":"crossref","unstructured":"Hu, Hongde et al. \u201cCoronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.\u201dEuropean Heart Journal. 42 (2) (2021): 206. 10.1093\/eurheartj\/ehaa190.","DOI":"10.1093\/eurheartj\/ehaa190"},{"key":"10.1016\/j.cyto.2024.156584_b0685","doi-asserted-by":"crossref","unstructured":"Mehra, Mandeep R et al. \u201cCardiovascular Disease, Drug Therapy, and Mortality in Covid-19.\u201dThe New England Journal of Medicine. 382(25) (2020): e102. 10.1056\/NEJMoa2007621.","DOI":"10.1056\/NEJMoa2007621"},{"issue":"1","key":"10.1016\/j.cyto.2024.156584_b0690","doi-asserted-by":"crossref","first-page":"e001957","DOI":"10.1136\/openhrt-2021-001957","article-title":"Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination","volume":"9","author":"Kornowski","year":"2022","journal-title":"Open Heart."},{"key":"10.1016\/j.cyto.2024.156584_b0695","unstructured":"McDonagh, Theresa A et al. \u201c2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.\u201dEuropean Heart Journal. 42(36) (2021): 3599-3726. 10.1093\/eurheartj\/ehab368."},{"key":"10.1016\/j.cyto.2024.156584_b0700","article-title":"\u201cCOVID-19 and myocarditis: a review of literature\u201d. the egyptian Heart journal: (EHJ): official bulletin of the egyptian society of","volume":"74 (1) 23","author":"Ali","year":"2022","journal-title":"Cardiology"},{"key":"10.1016\/j.cyto.2024.156584_b0705","doi-asserted-by":"crossref","unstructured":"Hong, Shukun et al. \u201cThe roles of methylprednisolone treatment in patients with COVID-19: A systematic review and meta-analysis.\u201dSteroids. 183 (2022): 109022. 10.1016\/j.steroids.2022.10902.","DOI":"10.1016\/j.steroids.2022.109022"},{"key":"10.1016\/j.cyto.2024.156584_b0710","doi-asserted-by":"crossref","unstructured":"Zhan, Yuan et al. \u201cEfficacy of corticosteroid in patients with COVID-19: A multi-center retrospective study and meta-analysis.\u201dJournal of Medical Virology. 93(7) (2021): 4292-4302. 10.1002\/jmv.26914.","DOI":"10.1002\/jmv.26914"},{"key":"10.1016\/j.cyto.2024.156584_b0715","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group et al. \u201cDexamethasone in Hospitalized Patients with Covid-19.\u201dThe New England journal of medicine. 384(8) (2021): 693-704. 10.1056\/NEJMoa2021436.","DOI":"10.1056\/NEJMoa2021436"},{"key":"10.1016\/j.cyto.2024.156584_b0720","article-title":"\u201cCorticosteroid adverse effects\u201d. StatPearls","author":"Yasir","year":"2023","journal-title":"StatPearls Publishing."},{"issue":"1","key":"10.1016\/j.cyto.2024.156584_b0725","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"issue":"13","key":"10.1016\/j.cyto.2024.156584_b0730","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156584_b0735","doi-asserted-by":"crossref","unstructured":"Abbate, Antonio et al. \u201cInterleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.\u201dCirculation Research. 126 (9) (2020): 1260-1280. 10.1161\/CIRCRESAHA.120.315937.","DOI":"10.1161\/CIRCRESAHA.120.315937"},{"key":"10.1016\/j.cyto.2024.156584_b0740","doi-asserted-by":"crossref","unstructured":"Ono, Ryohei et al. \u201cFulminant myocarditis with adult-onset Still's disease: case-based review.\u201dClinical Rheumatology. 42 (9) (2023): 2507-2514. 10.1007\/s10067-023-06648-y.","DOI":"10.1007\/s10067-023-06648-y"},{"key":"10.1016\/j.cyto.2024.156584_b0745","doi-asserted-by":"crossref","unstructured":"Trpkov, Cvetan et al. \u201cRapid Response to Cytokine Storm Inhibition Using Anakinra in a Patient With COVID-19 Myocarditis.\u201dCJC open. 3 (2) (2021): 210-213. 10.1016\/j.cjco.2020.10.003.","DOI":"10.1016\/j.cjco.2020.10.003"},{"issue":"80","key":"10.1016\/j.cyto.2024.156584_b0750","article-title":"Anakinra in pediatric acute fulminant myocarditis","volume":"12","author":"Maunier","year":"2022","journal-title":"Ann. Intensive Care"},{"issue":"24","key":"10.1016\/j.cyto.2024.156584_b0755","doi-asserted-by":"crossref","first-page":"e6656","DOI":"10.1097\/MD.0000000000006656","article-title":"Refractory adult-onset still disease complicated by macrophage activation syndrome and acute myocarditis: a case report treated with high doses (8 mg\/kg\/d) of anakinra","volume":"96","author":"Parisi","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.cyto.2024.156584_b0760","doi-asserted-by":"crossref","unstructured":"Chitturi, Kalyan R et al. \u201cSuccessful treatment of acute heart failure in COVID-19-induced cytokine storm with tocilizumab: a case report.\u201dEuropean Heart Journal. Case reports. 4(2020):1-6. 10.1093\/ehjcr\/ytaa188.","DOI":"10.1093\/ehjcr\/ytaa188"},{"issue":"17","key":"10.1016\/j.cyto.2024.156584_b0765","doi-asserted-by":"crossref","first-page":"8087","DOI":"10.1111\/jcmm.16798","article-title":"Anti-inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy","volume":"25","author":"Li","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.cyto.2024.156584_b0770","article-title":"A case of severe Cardiomyopathy due to covid-induced Myocarditis, completely resolved after colchicine and immunoglobulin therapy","volume":"10","author":"Khine","year":"2023","journal-title":"Eur. J. Case Reports Intern. Med."},{"issue":"2","key":"10.1016\/j.cyto.2024.156584_b0775","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/injr.injr_264_21","article-title":"Effectiveness of colchicine among patients with COVID-19 infection: a randomized, open-labeled, clinical trial","volume":"17","author":"Jalal","year":"2022","journal-title":"Indian J. Rheumatol."},{"issue":"9","key":"10.1016\/j.cyto.2024.156584_b0780","doi-asserted-by":"crossref","first-page":"e003870","DOI":"10.1161\/CIRCHEARTFAILURE.117.003870","article-title":"NOD2 (nucleotide-binding Oligomerization domain 2) is a major pathogenic mediator of coxsackievirus B3-induced Myocarditis","volume":"10","author":"Tsch\u00f6pe","year":"2017","journal-title":"Circulation Heart Failure"},{"issue":"12","key":"10.1016\/j.cyto.2024.156584_b0785","first-page":"1420","article-title":"\u201cMicrotubule inhibition therapy by colchicine in severe myocarditis especially caused by epstein-Barr and cytomegalovirus co-infection during a two-year period: a novel therapeutic approach\u201d. JPMA. the","volume":"64","author":"Gultekin","year":"2014","journal-title":"J. Pak. Med. Assoc."},{"issue":"1","key":"10.1016\/j.cyto.2024.156584_b0790","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9010121","article-title":"Intravenous immunoglobulins at the crossroad of autoimmunity and viral infections","volume":"9","author":"Perricone","year":"2021","journal-title":"Microorganisms."},{"key":"10.1016\/j.cyto.2024.156584_b0795","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2009.04022.x","article-title":"Intravenous immunoglobulins\u2013understanding properties and mechanisms","volume":"158","author":"Durandy","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156584_b0800","article-title":"\u201cIntravenous immunoglobulin for presumed viral myocarditis in children and adults\u201d. the","volume":"8","author":"Robinson","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cyto.2024.156584_b0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmcr.2022.101611","article-title":"Management of a critically ill patient with COVID-19-related fulminant myocarditis: a case report","volume":"36","author":"Shahrami","year":"2022","journal-title":"Respiratory Medicine Case Reports."},{"issue":"1","key":"10.1016\/j.cyto.2024.156584_b0810","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3892\/etm.2013.1372","article-title":"Intravenous immunoglobulin in the therapy of adult acute fulminant myocarditis: a retrospective study","volume":"7","author":"Yu","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.cyto.2024.156584_b0815","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/13543776.2019.1582646","article-title":"Aldose reductase inhibitors: 2013-present","volume":"29","author":"Quattrini","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.cyto.2024.156584_b0820","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biocel.2009.09.009","article-title":"Aldose reductase: a novel therapeutic target for inflammatory pathologies","volume":"42","author":"Kota","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156584_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.102328","article-title":"A pilot open-label study of aldose reductase inhibition with AT-001 (caficrestat) in patients hospitalized for COVID-19 infection: results from a registry-based matched-control analysis","volume":"15","author":"Gaztanaga","year":"2021","journal-title":"Diabetes & Metabolic Syndrome."},{"issue":"3","key":"10.1016\/j.cyto.2024.156584_b0830","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156584_b0835","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s10067-017-3971-4","article-title":"Lupus myocarditis receiving the rituximab therapy-a monocentric retrospective study","volume":"37","author":"Wang","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156584_b0840","first-page":"e38","article-title":"\u201cRituximab in recurrent idiopathic giant cell myocarditis after heart transplantation: a potential therapeutic approach\u201d. transplant international: official journal of the european Society for Organ","volume":"27","author":"Toscano","year":"2014","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cyto.2024.156584_b0845","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcr\/ytz131","article-title":"Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series","volume":"3","author":"Tsch\u00f6pe","year":"2019","journal-title":"Eur. Heart J. Case Reports."},{"issue":"7","key":"10.1016\/j.cyto.2024.156584_b0850","first-page":"E166","article-title":"Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology","volume":"7","author":"Makdisi","year":"2015","journal-title":"J. Thorac. Dis."},{"issue":"7","key":"10.1016\/j.cyto.2024.156584_b0855","doi-asserted-by":"crossref","first-page":"e010152","DOI":"10.1161\/CIRCHEARTFAILURE.122.010152","article-title":"Outcomes with peripheral Venoarterial Extracorporeal membrane oxygenation for suspected acute Myocarditis: 10-Year Experience from the Extracorporeal life support organization registry","volume":"16","author":"Nunez","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.cyto.2024.156584_b0860","unstructured":"\u201cCantargia Receives Regulatory Approval to Start Phase I Clinical Trial for CAN10 - Cantargia.\u201dCantargia.com, cantargia.com\/en\/press-releases\/cantargia-receives-regulatory-approval-to-start-phase-i-clinical-trial-for-can10. Accessed 29 Dec. 2023."},{"key":"10.1016\/j.cyto.2024.156584_b0865","unstructured":"\u201cCannabidiol 1 by Cardiol Therapeutics for Pericarditis: Likelihood of Approval.\u201d Pharmaceutical Technology, 7 June 2023, www.pharmaceutical-technology.com\/data-insights\/cannabidiol-1-cardiol-therapeutics-pericarditis-likelihood-of-approval."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T01:31:57Z","timestamp":1712626317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":178,"alternative-id":["S1043466624000875"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156584","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding long COVID myocarditis: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156584"}}